▁Vienna 11.2421875
, 1.7099609375
▁Austria 1.4228515625
▁- 2.29296875
▁In 4.86328125
▁a 2.150390625
▁significant 5.87109375
▁mil 3.025390625
estone 0.0006875991821289062
▁for 0.81005859375
▁the 0.818359375
▁British 8.921875
▁bi 5.4140625
ote 0.484619140625
ch 0.5771484375
▁sector 1.228515625
, 0.09307861328125
▁the 1.458984375
▁revolution 9.0625
ary 0.00475311279296875
▁anti 4.3984375
- 0.019134521484375
can 1.65625
cer 0.0007181167602539062
▁treatment 3.0625
▁Mar 8.546875
im 8.734375
ast 0.09002685546875
at 9.179115295410156e-06
, 2.220703125
▁developed 0.791015625
▁by 0.255859375
▁a 4.2265625
▁cutting 8.46875
- 0.3076171875
edge 0.007328033447265625
▁UK 1.79296875
▁bi 0.8076171875
ote 0.046630859375
ch 0.377685546875
▁firm 2.169921875
, 0.314208984375
▁is 1.6484375
▁set 1.7744140625
▁to 0.071533203125
▁under 3.5078125
go 0.0032901763916015625
▁a 1.8359375
▁compreh 6.4609375
ensive 0.000446319580078125
▁review 3.93359375
▁at 3.490234375
▁the 0.2919921875
▁up 4.671875
coming 0.01245880126953125
▁European 1.6376953125
▁Society 3.48828125
▁for 0.390380859375
▁Medical 0.052337646484375
▁On 0.0020751953125
col 0.00499725341796875
ogy 6.341934204101562e-05
▁( 0.175048828125
ES 0.006519317626953125
MO 0.00013315677642822266
) 0.0340576171875
▁conference 1.744140625
▁in 0.650390625
▁Vienna 0.2047119140625
. 0.8642578125
<0x0A> 0.626953125
Mar 1.4521484375
im 0.01049041748046875
ast 0.00029850006103515625
at 0.00025582313537597656
▁is 0.98388671875
▁a 0.8984375
▁prom 4.0390625
ising 0.003002166748046875
▁drug 2.916015625
▁designed 3.537109375
▁to 0.128662109375
▁combat 3.296875
▁cancer 1.3720703125
▁by 0.98046875
▁target 2.505859375
ing 0.003421783447265625
▁and 2.53515625
▁in 1.6630859375
hib 0.06378173828125
iting 0.0009479522705078125
▁the 1.162109375
▁growth 3.189453125
▁of 0.1590576171875
▁tum 1.8291015625
ors 3.357421875
. 0.748046875
▁This 3.0078125
▁ground 3.87890625
bre 0.4423828125
aking 2.944469451904297e-05
▁treatment 1.25
▁has 0.58154296875
▁spark 6.078125
ed 0.0013837814331054688
▁w 2.880859375
ides 5.733966827392578e-05
p 8.857250213623047e-05
read 6.9141387939453125e-06
▁excitement 1.9990234375
▁within 1.84765625
▁the 0.01177215576171875
▁medical 0.67236328125
▁community 0.0789794921875
▁due 1.9833984375
▁to 0.00511932373046875
▁its 0.025421142578125
▁potential 0.388671875
▁for 3.390625
▁significant 3.189453125
▁improvements 1.4794921875
▁in 0.06817626953125
▁cancer 1.142578125
▁ther 2.498046875
apy 0.210205078125
▁out 4.375
comes 6.175041198730469e-05
. 0.2301025390625
<0x0A> 0.246826171875
The 0.837890625
▁ES 1.4482421875
MO 0.00017452239990234375
▁conference 0.17236328125
, 1.1337890625
▁one 3.126953125
▁of 0.0008306503295898438
▁Europe 3.66796875
' 0.25048828125
s 0.00016999244689941406
▁most 1.095703125
▁pr 0.403564453125
estig 4.172325134277344e-06
ious 9.34600830078125e-05
▁gather 2.25
ings 0.007633209228515625
▁in 2.88671875
▁the 0.471923828125
▁field 0.1151123046875
▁of 0.07183837890625
▁medical 1.9892578125
▁on 0.02862548828125
col 0.000125885009765625
ogy 5.7220458984375e-06
, 0.0157928466796875
▁will 1.224609375
▁provide 1.16015625
▁a 0.66455078125
▁platform 1.1015625
▁for 0.03717041015625
▁exper 2.181640625
ts 7.62939453125e-06
▁to 0.962890625
▁scr 5.08984375
ut 9.894371032714844e-06
in 0.00016045570373535156
ize 0.043487548828125
▁the 1.009765625
▁scientific 4.48828125
▁adv 5.6640625
anc 0.96337890625
ements 0.00011181831359863281
▁and 1.986328125
▁effic 3.490234375
acy 0.003421783447265625
▁of 0.1634521484375
▁Mar 0.2265625
im 0.0017709732055664062
ast 0.0003097057342529297
at 0.0003628730773925781
. 0.427978515625
▁This 1.7783203125
▁review 1.955078125
▁a 6.51953125
ims 0.007266998291015625
▁to 0.0086517333984375
▁evaluate 2.958984375
▁the 0.17822265625
▁treatment 2.814453125
' 0.07452392578125
s 7.998943328857422e-05
▁safety 1.8984375
▁profile 1.974609375
, 0.63623046875
▁its 2.7578125
▁potential 0.78271484375
▁side 4.96875
▁effects 0.02093505859375
, 0.11248779296875
▁and 0.046356201171875
▁most 6.03125
▁important 0.20458984375
ly 0.0016994476318359375
, 0.1639404296875
▁its 0.2288818359375
▁effect 1.9130859375
iveness 0.0237579345703125
▁in 0.1246337890625
▁comb 1.9052734375
ating 0.061065673828125
▁various 1.8740234375
▁types 0.5810546875
▁of 0.0023059844970703125
▁cancer 0.2215576171875
. 0.1077880859375
<0x0A> 0.06689453125
Develop 5.921875
ed 0.0694580078125
▁by 0.0655517578125
▁the 1.6103515625
▁dedicated 8.1484375
▁team 0.43017578125
▁at 0.197509765625
▁the 2.341796875
▁British 2.03125
▁bi 0.1593017578125
ote 0.01265716552734375
ch 0.05511474609375
▁firm 0.304443359375
, 1.3916015625
▁the 2.814453125
▁treatment 2.119140625
' 3.158203125
s 0.00022685527801513672
▁mechanism 3.353515625
▁is 3.828125
▁centered 3.46875
▁around 0.52099609375
▁its 2.6171875
▁ability 0.45751953125
▁to 0.0003478527069091797
▁in 1.1826171875
hib 0.0015287399291992188
it 0.00013387203216552734
▁a 2.11328125
▁group 5.6796875
▁of 0.00136566162109375
▁en 0.40869140625
zym 2.2292137145996094e-05
es 0.0016183853149414062
▁known 0.65283203125
▁as 0.002750396728515625
▁matrix 0.93505859375
▁metal 0.01087188720703125
lo 0.00012826919555664062
prote 0.0214691162109375
in 0.0335693359375
ases 0.0220489501953125
▁( 0.1842041015625
M 0.006282806396484375
MP 6.222724914550781e-05
s 0.0258026123046875
). 0.412841796875
▁These 0.431884765625
▁en 0.04583740234375
zym 1.0728836059570312e-06
es 0.00017881393432617188
▁play 0.99853515625
▁a 0.11090087890625
▁cru 0.65625
cial 3.933906555175781e-06
▁role 0.000751495361328125
▁in 0.0003077983856201172
▁the 0.86572265625
▁pro 2.134765625
gression 0.14306640625
▁and 1.4462890625
▁spread 0.763671875
▁of 0.00861358642578125
▁tum 2.34765625
ors 0.10137939453125
▁and 3.791015625
▁cancer 3.14453125
ous 2.392578125
▁cells 0.355712890625
. 1.0419921875
▁By 0.36962890625
▁hal 6.71484375
ting 1.7642974853515625e-05
▁their 1.0556640625
▁activity 0.2476806640625
, 0.0338134765625
▁Mar 0.100830078125
im 0.0007109642028808594
ast 0.0001443624496459961
at 0.00013339519500732422
▁a 3.634765625
ims 0.05218505859375
▁to 0.00039887428283691406
▁imp 3.439453125
ede 0.02032470703125
▁the 0.235595703125
▁ag 6.15625
gress 0.010101318359375
ive 0.05194091796875
▁growth 0.3447265625
▁and 0.87890625
▁expansion 3.505859375
▁of 0.0028209686279296875
▁cancer 1.0185546875
, 3.037109375
▁potentially 1.9111328125
▁offering 2.982421875
▁a 0.62353515625
▁new 1.1025390625
▁weapon 3.88671875
▁in 0.11468505859375
▁the 0.01306915283203125
▁fight 0.202880859375
▁against 0.0009350776672363281
▁this 0.6279296875
▁dev 0.81103515625
ast 3.743171691894531e-05
ating 0.0004863739013671875
▁disease 0.04071044921875
. 0.0022029876708984375
<0x0A> 0.0076446533203125
E 6.046875
ar 0.481689453125
ly 0.08929443359375
▁pre 5.30859375
cl 0.464599609375
in 1.9431114196777344e-05
ical 0.0001398324966430664
▁tri 2.357421875
als 9.298324584960938e-06
▁have 0.76416015625
▁demonstrated 1.3037109375
▁prom 1.21484375
ising 2.7060508728027344e-05
▁results 0.09283447265625
, 0.50537109375
▁showing 3.484375
▁Mar 3.130859375
im 0.0009546279907226562
ast 0.0001577138900756836
at 0.00019621849060058594
' 0.31982421875
s 0.00015461444854736328
▁ability 1.5654296875
▁to 0.000370025634765625
▁effectively 1.94140625
▁suppress 1.9873046875
▁tum 0.84033203125
or 0.0701904296875
▁growth 0.1292724609375
▁in 1.53125
▁various 0.87841796875
▁types 1.705078125
▁of 0.001544952392578125
▁cancer 0.13232421875
, 0.5595703125
▁including 0.081298828125
▁breast 1.03515625
▁and 2.47265625
▁col 1.51171875
ore 0.0002942085266113281
ct 3.921985626220703e-05
al 0.0002532005310058594
▁cancer 0.405029296875
. 0.08306884765625
▁Such 5.6953125
▁positive 2.94921875
▁out 1.6513671875
comes 0.000606536865234375
▁have 0.33935546875
▁generated 2.658203125
▁significant 1.435546875
▁anticip 3.951171875
ation 0.0013265609741210938
, 4.35546875
▁leading 3.5390625
▁research 6.26953125
ers 0.006862640380859375
▁and 0.78955078125
▁health 2.58984375
care 0.09210205078125
▁profession 0.1732177734375
als 3.2186508178710938e-06
▁to 0.3583984375
▁eager 1.7880859375
ly 1.8596649169921875e-05
▁await 0.2291259765625
▁the 0.179931640625
▁outcome 2.35546875
▁of 0.0025196075439453125
▁the 0.1331787109375
▁rig 5.9296875
orous 0.0008449554443359375
▁evaluation 2.337890625
▁at 0.646484375
▁the 0.338623046875
▁ES 0.54150390625
MO 3.910064697265625e-05
▁conference 0.0190277099609375
. 0.07720947265625
<0x0A> 0.012908935546875
Dr 4.7421875
. 0.175048828125
▁Cla 5.92578125
ire 0.7392578125
▁Hamilton 6.921875
, 0.1329345703125
▁the 1.375
▁lead 2.181640625
▁research 1.009765625
er 0.0030345916748046875
▁behind 0.9921875
▁Mar 0.67724609375
im 0.001026153564453125
ast 0.00012123584747314453
at 0.000118255615234375
' 1.2568359375
s 0.00023281574249267578
▁development 0.050262451171875
, 0.1341552734375
▁expressed 1.6845703125
▁her 0.2056884765625
▁excitement 0.4169921875
▁about 1.419921875
▁the 0.0684814453125
▁treatment 2.98828125
' 0.0215911865234375
s 3.886222839355469e-05
▁up 2.548828125
coming 4.0411949157714844e-05
▁review 0.36962890625
, 1.6728515625
▁stating 0.31396484375
, 0.75732421875
▁" 0.0271759033203125
Mar 3.845703125
im 0.0004210472106933594
ast 8.499622344970703e-05
at 0.0001308917999267578
▁represents 1.859375
▁a 0.10992431640625
▁ground 3.451171875
bre 0.05340576171875
aking 1.5497207641601562e-06
▁approach 2.392578125
▁to 0.08636474609375
▁cancer 0.470947265625
▁treatment 0.64501953125
. 2.205078125
▁The 2.908203125
▁ES 1.056640625
MO 6.175041198730469e-05
▁review 3.064453125
▁is 1.1728515625
▁an 1.107421875
▁un 5.203125
par 1.35546875
alle 9.799003601074219e-05
led 5.960464477539062e-07
▁opportunity 0.0302276611328125
▁for 1.349609375
▁expert 6.03125
▁evaluation 3.337890625
, 1.8916015625
▁opening 6.44921875
▁the 0.60009765625
▁door 0.171142578125
▁for 0.8125
▁potential 1.669921875
▁world 6.1796875
wide 0.1796875
▁accept 3.1015625
ance 0.0005507469177246094
▁and 1.0517578125
▁w 2.80859375
ides 0.00023615360260009766
p 0.0008864402770996094
read 6.079673767089844e-06
▁use 1.107421875
▁of 0.783203125
▁this 0.310302734375
▁novel 2.880859375
▁th 3.169921875
era 1.800060272216797e-05
pe 1.2159347534179688e-05
ut 9.894371032714844e-06
ic 0.0007891654968261719
▁option 1.748046875
." 0.374267578125
<0x0A> 0.0244140625
The 0.8154296875
▁conference 3.25
▁is 1.80859375
▁expected 1.60546875
▁to 8.511543273925781e-05
▁attract 1.0791015625
▁prominent 4.76953125
▁on 1.74609375
colog 0.412841796875
ists 0.00197601318359375
, 1.04296875
▁medical 1.8642578125
▁research 1.0751953125
ers 0.003879547119140625
, 0.0035037994384765625
▁and 0.038116455078125
▁industry 1.5615234375
▁exper 1.4072265625
ts 4.0531158447265625e-06
▁from 0.309326171875
▁around 0.74169921875
▁the 0.00464630126953125
▁glo 0.92626953125
be 1.1920928955078125e-06
. 1.1572265625
▁The 1.1552734375
▁critical 6.296875
▁analysis 2.494140625
▁and 1.8759765625
▁strateg 9.03125
ic 0.009674072265625
▁discussion 2.515625
▁of 0.91552734375
▁Mar 0.2900390625
im 0.0010271072387695312
ast 7.152557373046875e-05
at 6.568431854248047e-05
' 0.243408203125
s 3.7789344787597656e-05
▁effic 1.5732421875
acy 7.867813110351562e-06
▁will 2.298828125
▁fuel 5.9296875
▁further 1.767578125
▁ins 5.609375
ights 0.0005197525024414062
▁into 0.470458984375
▁the 0.4853515625
▁potential 1.6220703125
▁value 6.37890625
▁it 3.736328125
▁may 1.6044921875
▁bring 1.03515625
▁to 0.052490234375
▁the 0.58203125
▁field 1.23046875
▁of 0.053070068359375
▁cancer 0.416259765625
▁ther 1.263671875
apy 0.0025997161865234375
. 0.1522216796875
<0x0A> 0.16064453125
Wh 3.947265625
ile 0.004974365234375
▁Mar 2.64453125
im 0.00083160400390625
ast 5.543231964111328e-05
at 0.00010132789611816406
▁still 3.939453125
▁has 2.890625
▁a 0.466552734375
▁long 0.053985595703125
▁journey 1.5810546875
▁before 4.6875
▁it 0.3759765625
▁can 0.5068359375
▁be 0.568359375
▁made 2.02734375
▁available 0.269287109375
▁to 0.155517578125
▁patients 0.48681640625
, 0.192138671875
▁the 0.27099609375
▁ES 1.2646484375
MO 9.119510650634766e-05
▁review 0.80517578125
▁is 1.203125
▁a 0.353759765625
▁significant 0.7998046875
▁step 0.833984375
▁towards 1.6748046875
▁gain 6.34765625
ing 5.2928924560546875e-05
▁regul 3.953125
atory 0.00030422210693359375
▁appro 0.03179931640625
val 2.0384788513183594e-05
▁and 0.2939453125
▁progress 6.375
ing 0.0787353515625
▁towards 0.83447265625
▁clin 1.279296875
ical 0.0006055831909179688
▁tri 0.1627197265625
als 2.0623207092285156e-05
. 0.1348876953125
▁If 3.36328125
▁successful 0.5888671875
, 0.02081298828125
▁this 1.634765625
▁anti 3.99609375
- 0.00013959407806396484
can 0.01194000244140625
cer 1.537799835205078e-05
▁break 5.11328125
through 8.821487426757812e-05
▁could 0.71923828125
▁revolution 1.21484375
ize 0.001293182373046875
▁treatment 4.41796875
▁options 1.107421875
▁and 1.27734375
▁provide 2.703125
▁renew 4.93359375
ed 4.1961669921875e-05
▁hope 0.0086517333984375
▁for 0.64453125
▁count 2.74609375
less 3.2186508178710938e-06
▁individuals 0.98779296875
▁affected 1.8134765625
▁by 0.0003345012664794922
▁cancer 1.357421875
▁world 1.57421875
wide 4.5418739318847656e-05
. 0.006130218505859375
<0x0A> 0.280517578125
As 2.703125
▁anticip 7.2734375
ation 0.00579071044921875
▁mount 2.390625
s 7.05718994140625e-05
, 1.25
▁the 0.70947265625
▁global 3.8359375
▁medical 1.1396484375
▁community 0.0576171875
▁eager 0.6162109375
ly 5.14984130859375e-05
▁a 0.01214599609375
wa 4.410743713378906e-06
its 5.960464477539062e-07
▁the 0.04156494140625
▁out 1.873046875
comes 0.00027680397033691406
▁of 0.033721923828125
▁the 0.24365234375
▁compreh 3.546875
ensive 3.24249267578125e-05
▁review 0.58740234375
▁at 1.5966796875
▁the 0.10467529296875
▁ES 1.1875
MO 4.696846008300781e-05
▁conference 0.01497650146484375
, 1.423828125
▁recogn 5.94921875
izing 0.0015430450439453125
▁that 2.923828125
▁it 2.478515625
▁could 1.1591796875
▁shape 4.453125
▁the 0.07147216796875
▁future 0.07330322265625
▁of 0.043426513671875
▁cancer 0.038970947265625
▁treatment 0.7705078125
▁practices 10.3359375
. 0.57373046875
